ViroPharma Receives FDA Approval of Cinryze
ViroPharma Incorporated (Nasdaq: VPHM) today announced the U.S. Food and Drug Administration (FDA) has approved the supplement to the Cinryze Biologics License Application (BLA) for industrial scale manufacturing changes. As previously announced, the company expects completion of labeling for previously produced vials to take approximately six weeks before entering into the trade.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.